Table 1 (cont'd) Pt. No. & sex Age 1979 Est. thyroid dose (rads) Thyroid Nodularities Age at detection Surgery Diagnosis Hypofunction TSH (uU/d1) (c) Rongelap exposed at age >18 18 F 64 F 4M 45 55 63 335 335 335 71 F 34 F 66 F 52 70 55 335 335 335 78 F662 34 4] Cleve. '69 Bost. '65 Papillary Ca Papillary Ca 335 6.0, 7.0 6.6, 8.8 55 Cleve. '79 Adenomatous nod. Cleve. '72 Cleve. ‘81 Adenomatous nod. Occult Pap. Ca 6.5, 7.0 6.3, 8.3 (d) Ailingnae exposed at age <10 8 F 53 F 26 33 450 320 18 28 (e) Ailingnae exposed at age 10-18: and adenomatous nod. NONE (f) Ailingnae exposed at age >18 51 F 45 ¥F 50 57 135 135 45 51 Cleve. '74 Cleve. '73 59 F -— 135 53 Bost. 16 M 64 41 M 69 135 '66 135 Adenoma Adenomatous nod. Nodule Adenomatous nod. (died '68, age 54) 6.4, 6.5 (g) Utirik exposed at age <10 2160 F 2154 F 29 31 80 75 25 28 Cleve. ‘75 2147 F 2239 F 2132 F 26 28 27 90 80 80 25 28 27 Cleve. '79 Cleve. ‘81 Cleve. ‘81 Papillary Ca Nodule reduced '79 Adenomatous nod. " " " " Cleve. '76 Adenoma (h) Utirik exposed at age 10-18 2229 F 2150 M 43 37 54 33 32 Cleve. 2236 M 36 55 34 Hono. 31 '69 ‘78 ~ 126 - Papillary Ca vs. atypical adenoma Adenoma